Free Trial

Strata Skin Sciences (SSKN) Competitors

Strata Skin Sciences logo
$2.01 -0.01 (-0.50%)
As of 12:55 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

SSKN vs. POCI, COCH, VVOS, DRIO, FEMY, CLGN, ALUR, IRIX, BDMD, and OSRH

Should you be buying Strata Skin Sciences stock or one of its competitors? The main competitors of Strata Skin Sciences include Precision Optics (POCI), Envoy Medical (COCH), Vivos Therapeutics (VVOS), DarioHealth (DRIO), Femasys (FEMY), CollPlant Biotechnologies (CLGN), Allurion Technologies (ALUR), IRIDEX (IRIX), Baird Medical Investment (BDMD), and OSR (OSRH). These companies are all part of the "medical equipment" industry.

Strata Skin Sciences vs. Its Competitors

Precision Optics (NASDAQ:POCI) and Strata Skin Sciences (NASDAQ:SSKN) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, earnings, institutional ownership, profitability, media sentiment and dividends.

Precision Optics has a beta of 0.25, suggesting that its stock price is 75% less volatile than the S&P 500. Comparatively, Strata Skin Sciences has a beta of 0.69, suggesting that its stock price is 31% less volatile than the S&P 500.

In the previous week, Strata Skin Sciences had 1 more articles in the media than Precision Optics. MarketBeat recorded 2 mentions for Strata Skin Sciences and 1 mentions for Precision Optics. Precision Optics' average media sentiment score of 1.87 beat Strata Skin Sciences' score of 0.94 indicating that Precision Optics is being referred to more favorably in the media.

Company Overall Sentiment
Precision Optics Very Positive
Strata Skin Sciences Positive

13.7% of Precision Optics shares are held by institutional investors. Comparatively, 32.4% of Strata Skin Sciences shares are held by institutional investors. 13.0% of Precision Optics shares are held by company insiders. Comparatively, 39.0% of Strata Skin Sciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Precision Optics has higher earnings, but lower revenue than Strata Skin Sciences. Precision Optics is trading at a lower price-to-earnings ratio than Strata Skin Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Precision Optics$19.10M1.96-$2.95M-$0.89-5.48
Strata Skin Sciences$33.56M0.25-$10.09M-$2.27-0.89

Strata Skin Sciences has a net margin of -27.22% compared to Precision Optics' net margin of -32.84%. Precision Optics' return on equity of -54.03% beat Strata Skin Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Precision Optics-32.84% -54.03% -32.48%
Strata Skin Sciences -27.22%-138.22%-24.37%

Strata Skin Sciences has a consensus target price of $6.00, suggesting a potential upside of 198.51%. Given Strata Skin Sciences' stronger consensus rating and higher possible upside, analysts clearly believe Strata Skin Sciences is more favorable than Precision Optics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Precision Optics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Strata Skin Sciences
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Strata Skin Sciences beats Precision Optics on 11 of the 16 factors compared between the two stocks.

Get Strata Skin Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for SSKN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SSKN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SSKN vs. The Competition

MetricStrata Skin SciencesMEDICAL INFO SYS IndustryMedical SectorNASDAQ Exchange
Market Cap$8.38M$2.11B$5.70B$9.51B
Dividend YieldN/AN/A4.60%3.99%
P/E Ratio-0.8937.3227.9419.99
Price / Sales0.2510.66456.59102.06
Price / CashN/A56.5036.5558.97
Price / Book1.699.068.585.86
Net Income-$10.09M-$63.59M$3.24B$258.50M
7 Day Performance-8.64%2.48%3.67%1.89%
1 Month Performance-12.61%11.52%10.24%12.18%
1 Year Performance-39.09%6.98%34.02%18.94%

Strata Skin Sciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SSKN
Strata Skin Sciences
3.2093 of 5 stars
$2.01
-0.5%
$6.00
+198.5%
-39.9%$8.38M$33.56M-0.89120Gap Up
POCI
Precision Optics
0.7224 of 5 stars
$4.81
+1.1%
N/A-22.8%$36.49M$19.10M-5.4080Gap Up
COCH
Envoy Medical
3.1049 of 5 stars
$1.61
flat
$9.25
+474.5%
-24.9%$34.34M$220K-1.1734
VVOS
Vivos Therapeutics
1.2903 of 5 stars
$5.44
-6.5%
$4.82
-11.5%
+122.1%$34.28M$15.03M-3.14160Positive News
DRIO
DarioHealth
2.096 of 5 stars
$0.70
+2.8%
$2.00
+183.7%
-44.0%$30.50M$27.04M-1.26200
FEMY
Femasys
3.1794 of 5 stars
$0.88
-0.2%
$8.67
+882.6%
-21.1%$28.75M$1.63M-0.9730Positive News
CLGN
CollPlant Biotechnologies
2.7821 of 5 stars
$2.24
+10.3%
$11.50
+413.4%
-50.0%$25.81M$510K-1.8470High Trading Volume
ALUR
Allurion Technologies
2.9059 of 5 stars
$3.17
+0.8%
$22.83
+621.4%
-86.4%$23.42M$32.11M-0.25501
IRIX
IRIDEX
0.9917 of 5 stars
$1.26
flat
N/A-34.0%$21.15M$48.67M-2.93120Gap Up
High Trading Volume
BDMD
Baird Medical Investment
N/A$3.06
-1.9%
N/AN/A$20.54MN/A0.00N/A
OSRH
OSR
N/A$1.08
+1.9%
N/AN/A$20.43MN/A0.00N/ANews Coverage

Related Companies and Tools


This page (NASDAQ:SSKN) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners